My thought is this:
Generic drugs businesses will be consolidated and merged to survive. PFE is smart to pick the least exposed.
TEVA is in deep hole/value....
ENDP and MNK should be merged.
Maybe TEVA should merge with ENDP and MNK.
Long MYL, TEVA and looking to add the others.